Life expectancy of adult liver allograft recipients in the UK

Barber, K.; Blackwell, J.; Collett, D.; Neuberger, J.
February 2007
Gut;Feb2007, Vol. 56 Issue 2, p279
Academic Journal
Background: Liver transplantation is a very successful therapy for those with end stage disease. Although there are numerous data on patient and graft survival after liver transplantation, life expectancy and possible loss of life (compared with a normal matched population) in those who survive remains unknown. Aims: To assess the life expectancy and life years lost of adult liver allograft recipients, compared with an age and sex matched UK population to provide patients with more information and to improve the use of a scarce resource. Methods: Using the National Transplant Database held by UK Transplant, on over 3600 adult liver allograft recipients transplanted between 1985 and 2003, we analysed survival of all adults who survived more than six months after transplantation and compared survival after transplantation with national age and sex matched controls to assess life years lost. Results: Estimated median survival time of the analysis cohort of 2702 adult liver allograft recipients was 22.2 years (95% confidence interval 19.3-25.6), with an estimated loss of seven life years compared with an age and sex matched population. Conclusions: Overall, female recipients have a longer life expectancy and lose fewer life years than male recipients. While younger recipients have a longer life expectancy, they also lose more life years. Those transplanted for cancer, hepatitis C virus infection, and alcoholic liver disease had the greatest loss of life years.


Related Articles

  • Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Wali, M.; Harrison, R.F.; Gow, P.J.; Mutimer, D. // Gut;Aug2002, Vol. 51 Issue 2, p248 

    Background and aims: Cirrhosis with liver failure due to hepatitis C virus (HCV) infection is the most common indication for liver transplantation (LT). Reinfection of the transplanted liver by HCV is inevitable, and aggressive hepatitis with accelerated progression to graft cirrhosis may be...

  • Liver Transplantation for Alcoholic Liver Disease with or Without Hepatitis C. Goldar-Najafi, Atoussa; Gordon, Fredric D.; Lewis, W. David; Pomfret, Elizabeth; Pomposelli, James J.; Jenkins, Roger L.; Khettry, Urmila // International Journal of Surgical Pathology;Apr2002, Vol. 10 Issue 2, p115 

    Examines the impact of concomitant hepatitis C virus (HCV) on alcoholic liver disease patients undergoing liver transplantation (LT). Number of patients with cirrhosis at LT; List of native liver features; Recurrence of post-LT HCV.

  • Natural history of hepatitis C recurrence after liver and liver/kidney combined transplantation. Serper, Marina; Levitsky, Josh // Hot Topics in Viral Hepatitis;2012, Vol. 8 Issue 23, p13 

    Hepatitis C virus (HCV) has a very high disease burden worldwide and is currently the leading cause of liver transplantation. Post-transplant reinfection of the liver graft is universal and progression to recurrent hepatitis and fibrosis as well as clinical decompensation can occur at an...

  • HEPATITIS C Damage Done. Feldman, Leslie // For the Record (Great Valley Publishing Company, Inc.);1/30/2012, Vol. 24 Issue 2, p24 

    The article looks at research progress on how to combat hepatitis C, the leading cause of liver disease in the U.S. and the primary reason for liver transplants in the country. It discusses the heightened awareness of the destructiveness of hepatitis C virus (HCV) and the epidemiology of...

  • Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe. Singaravelu, Ragunath; Blais, David R.; McKay, Craig S.; Pezacki, John Paul // Proteome Science;2010, Vol. 8, p5 

    Background: Hepatitis C virus (HCV) poses a growing threat to global health as it often leads to serious liver diseases and is one of the primary causes for liver transplantation. Currently, no vaccines are available to prevent HCV infection and clinical treatments have limited success. Since...


    The risk of hepatitis C virus (HCV) transmission from patients to surgeons is related to the prevalence of HCV in the surgical patient population. As HCV related cirrhosis is the commonest indication for liver transplantation in Europe and North America, liver transplant surgeons would be...

  • The economic burden of advanced liver disease among patients with Hepatitis C Virus: a large state Medicaid perspective. Menzin, Joseph; White, Leigh Ann; Nichols, Christine; Deniz, Baris // BMC Health Services Research;2012, Vol. 12 Issue 1, p459 

    Background: Chronic hepatitis C virus (HCV) may progress to advanced liver disease (ALD), including decompensated cirrhosis and/or hepatocellular carcinoma (HCC). ALD can lead to significant clinical and economic consequences, including liver transplantation. This study evaluated the health care...

  • The Pathogenesis of Hepatitis C Virus Is Influenced by Cytomegalovirus. Razonable, Raymund R.; Burak, Kelly W.; Van Cruijsen, Hester; Brown, Robert A.; Charlton, Michael R.; Smith, Thomas F.; Epsy, Mark J.; Kremers, Walter; Wilson, Jennie A.; Groettum, Cynthia; Wiesner, Russell; Paya, Carlos V. // Clinical Infectious Diseases;10/15/2002, Vol. 35 Issue 8, p974 

    We investigated the effect of �-herpesviruses on allograft failure and mortality, hepatitis C virus (HCV) replication, and liver histologic characteristics among 92 HCV-infected liver transplant recipients. Reactivation of cytomegalovirus (CMV) but not of human herpesvirus 6 (HHV-6) was...

  • Molecular Pathways Differentiate Hepatitis C Virus (HCV) Recurrence from Acute Cellular Rejection in HCV Liver Recipients. Gehrau, Ricardo; Maluf, Daniel; Archer, Kellie; Stravitz, Richard; Suh, Jihee; Le, Ngoc; Mas, Valeria // Molecular Medicine;Jul/Aug2011, Vol. 17 Issue 7/8, p824 

    Acute cellular rejection (ACR) and hepatitis C virus (HCV) recurrence (HCVrec) are common complications after liver transplantation (LT) in HCV patients, who share common clinical and histological features, making a differential diagnosis difficult. Fiftythree liver allograft samples from unique...


Read the Article


Sign out of this library

Other Topics